Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Chapple

Showing results (11-20 of 271) with videos related to

Pageof 28
Sort By:
BJU International|August 27, 2004
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinicianChristopher R Chapple
Nature Reviews. Urology|July 7, 2009
Urinary incontinence: oxybutynin topical gel for overactive bladderChristopher R Chapple
International Journal of Urology : Official Journal of the Japanese Urological Association|June 6, 2018
Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β<sub>3</sub> -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective studyChristopher R Chapple
Urology|September 6, 2003
Urology. IntroductionChristopher R Chapple
European Urology|March 9, 2012
Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms?Christopher R Chapple
BJU International|February 19, 2020
A contemporary view on the use of slings and artificial urinary sphincters for the treatment of post-prostatectomy incontinence in EnglandChristopher R Chapple
The Journal of Urology|December 25, 2016
25 Years of Experience with the AUA Symptom Index: Increasing Recognition that the Bladder is an Unreliable WitnessChristopher R Chapple
European Urology|March 9, 2006
Duloxetine for male stress incontinenceChristopher R Chapple
European Urology|May 20, 2014
Is a voiding diary really necessary in 2014?Christopher R Chapple
European Urology|August 21, 2012
β3-agonist therapy: a new advance in the management of overactive bladder?Christopher R Chapple
Pageof 28

Showing results (11-20 of 271) with videos related to

Sort By:
Pageof 28
BJU International|August 27, 2004
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinicianChristopher R Chapple
Nature Reviews. Urology|July 7, 2009
Urinary incontinence: oxybutynin topical gel for overactive bladderChristopher R Chapple
International Journal of Urology : Official Journal of the Japanese Urological Association|June 6, 2018
Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β<sub>3</sub> -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective studyChristopher R Chapple
Urology|September 6, 2003
Urology. IntroductionChristopher R Chapple
European Urology|March 9, 2012
Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms?Christopher R Chapple
BJU International|February 19, 2020
A contemporary view on the use of slings and artificial urinary sphincters for the treatment of post-prostatectomy incontinence in EnglandChristopher R Chapple
The Journal of Urology|December 25, 2016
25 Years of Experience with the AUA Symptom Index: Increasing Recognition that the Bladder is an Unreliable WitnessChristopher R Chapple
European Urology|March 9, 2006
Duloxetine for male stress incontinenceChristopher R Chapple
European Urology|May 20, 2014
Is a voiding diary really necessary in 2014?Christopher R Chapple
European Urology|August 21, 2012
β3-agonist therapy: a new advance in the management of overactive bladder?Christopher R Chapple
Pageof 28